| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-11 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |